Recruiting NCT02193464
Inflammatory Bowel Disease Registry in Daegu-Gyeongbuk
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Idiopathic Chronic Inflammatory Bowel Disease. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- South Korea
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Observational Study Using Inflammatory Bowel Disease Registry in Daegu-Gyeongbuk, Southeastern Area of Korea
Overview
The purpose of this study is to investigate the incidence and natural course of inflammatory bowel disease in the southeastern area of Korea.
Primary outcome measures
- All newly diagnosed cases [Time frame: one year]
Secondary outcome measures (1)
- All operation cases [Time frame: one year]
Eligibility criteria
Inclusion criteria
- Clinical diagnosis of inflammatory bowel disease including Crohn's disease and ulcerative colitis
- Followed up for at least 6 months for the correct diagnosis
Exclusion criteria
- Patients who do not live in Daegu-Gyeongbuk province
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
South Korea · 1 center
- Keimyung University Dongsan Medical Center — Daegu
Identifiers
NCT: NCT02193464 · EPICODE